Is ERAS stock safe? | Glauxie AI

Q: Is ERAS stock safe?

Erasca, Inc. (ERAS) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Jonathan E. Lim. Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead... Employees: 200,000.

Q: What are the risks of investing in ERAS?

Identify key risks of investing in ERAS — debt, competition, volatility, and sector headwinds.

Q: Is ERAS a good long-term investment?

Evaluate ERAS as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does ERAS have?

Review ERAS total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is ERAS stock safe?

🦉

Erasca, Inc. (ERAS)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOJonathan E. Lim

Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer,...

Key Executives

Name	Title
Alison Tjosvold Milhous	Senior Vice President of Accounting
Brian L. Baker	Senior Vice President of Finance
Chandra D. Lovejoy	Chief Regulatory Affairs Officer
David Chacko	Chief Financial Officer & Chief Business Officer
Dawei Xuan	Senior Vice President of Clinical Pharmacology
Ebun S. Garner	Chief Legal Officer & Corporate Secretary

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ERAS Profile Financials

What are the risks of investing in ERAS? Is ERAS a good long-term investment? How much debt does ERAS have?